Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation.
about
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewThe role of chemotherapy and/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinomaMultiple scalp metastases from colonic neuroendocrine carcinoma: case report and literature review.Downgrading of a G3 Neuroendocrine Tumor to a G2 Tumor: Can First-Line Cytotoxic Chemotherapy Change the Tumor Biology?
P2860
Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chemo-hormone therapy of non-w ...... elease lanreotide formulation.
@ast
Chemo-hormone therapy of non-w ...... elease lanreotide formulation.
@en
type
label
Chemo-hormone therapy of non-w ...... elease lanreotide formulation.
@ast
Chemo-hormone therapy of non-w ...... elease lanreotide formulation.
@en
prefLabel
Chemo-hormone therapy of non-w ...... elease lanreotide formulation.
@ast
Chemo-hormone therapy of non-w ...... elease lanreotide formulation.
@en
P2093
P2860
P356
P1476
Chemo-hormone therapy of non-w ...... elease lanreotide formulation.
@en
P2093
A Guarnieri
A Pascucci
A Sciandivasci
C Intrivici
G Francini
L Voltolini
M Di Bisceglie
M T Del Vecchio
P Correale
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603734
P407
P577
2007-04-17T00:00:00Z
P5875
P6179
1039429307